Current assets
EX-10.1 2 c49369exv10w1.htm EX-10.1 EX-10.1
CARDIOVASCULAR SYSTEMS, INC.
651 CAMPUS DRIVE
ST. PAUL MN 55112-3495
Account Number: CP 03041
Exhibit 10.1
UBS Financial Services Inc. |
Please complete and sign this form.
We must receive it by November 14, 2008.
We must receive it by November 14, 2008.
Acceptance of UBSs offer relating to auction rate securities.
By signing below and returning this form, I accept UBSs offer of Rights relating to my Eligible ARS in the account listed below. I understand and acknowledge the following:
| All Eligible ARS must remain in my UBS account listed below until I exercise my Rights to sell my Eligible ARS to UBS or they are redeemed by the issuer or purchased or sold on my behalf by UBS; | |
| I will instruct my UBS Financial Advisor or Branch Manager if and when I want to exercise my Rights and sell my Eligible ARS to UBS during the period of June 30, 2010, through July 2, 2012; | |
| The acceptance of UBSs offer constitutes consent (to the extent legally required) for UBS, acting as principal, to purchase my Eligible ARS or to sell them on my behalf at any time in its sole discretion and without other prior notice to me, from the date that I accept this offer through July 2, 2012; | |
| If UBS purchases, sells or otherwise disposes of my Eligible ARS, it will deposit the par value in my account within one business day of settlement of the transaction; | |
| I release UBS and its employees/agents from all claims except claims for consequential damages directly or indirectly relating to its marketing and sale of ARS and expressly agree that I will not seek any damages or costs (punitive damages, attorney fees, etc.) other than consequential damages. I also will not serve as a class representative or receive benefits under any class action settlement or investor fund; | |
| If the account named below is in the name of a corporation, partnership, trust or other entity, I represent and warrant that I have the power and authority to accept this offer on behalf of that entity. |
CARDIOVASCULAR SYSTEMS, INC.
651 CAMPUS DRIVE
ST. PAUL MN 55112-3495
Account Number: CP 03041
Please complete and sign this form.
We must receive it by November 14, 2008.
We must receive it by November 14, 2008.
Mail | UBS Financial Services Inc. | |
ATTN: ARS Group | ||
1000 Harbor Boulevard | ||
Weehawken, NJ 07086 | ||
Fax | + ###-###-#### |
Account owner signature | /s/ James Flaherty | Date | 11/7/08 | |||||||
Additional party signature | /s/ Michael J. Kallok | Date | 11/7/2008 | |||||||
Daytime telephone number | 651 ###-###-#### | |||||||||
If you have questions, please contact your UBS Financial Advisor or Branch Manager at + ###-###-####.
Clients outside the U.S. may call + ###-###-#### collect.
Clients outside the U.S. may call + ###-###-#### collect.
We kindly request that you do not include comments or questions on this form as it could delay processing of your instructions.
UBS AG has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you make an investment decision, you should read the prospectus in that registration statement and other documents that UBS has filed with the SEC for more complete information about UBS and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov or by calling UBSs ARS Client Service Center at + ###-###-####.
UBS Financial Services Inc. serves as the clearing firm for UBS International Inc. Accordingly, the information and terms contained in this letter and the accompanying materials are directed to clients of both UBS Financial Services Inc and UBS International Inc.
©2008 UBS Financial Services Inc. All rights reserved. Member SIPC. | 1C-ARSO |
000336